EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers

Ravi Bharadwaj, Swati Jaiswal iD, Erandi E Velarde de la Cruz iD, Ritesh P Thakare iD

Diseases · 21.03.2024 · 12 (3) · 63

DOI: 10.3390/diseases12030063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 21.03.2024. Verfasst von Ravi Bharadwaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, UMass Chan Medical School, Worcester, MA 01605, USA. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solute carrier (SLC) transporters constitute a vast superfamily of transmembrane proteins tasked with regulating the transport of various substances such as metabolites, nutrients, ions, and drugs across cellular membranes. SLC transporters exhibit coordinated expression patterns across normal tissues, suggesting a tightly regulated regulatory network governing normal cellular functions. These transporters are crucial for the transport of various metabolites, including carbohydrates, proteins, lipids, and nucleic acids. However, during tumor development, metabolic changes drive an increased demand for energy and nutrients. Consequently, tumor cells alter the expression of SLC transporters to meet their heightened nutrient requirements. Targeting SLCs through inhibition or activation presents a promising therapeutic approach in cancer treatment. Certain SLCs also serve as intriguing chemo-sensitizing targets, as modulating their activity can potentially alter the response to chemotherapy. This review underscores the significance of various SLCs in tumor progression and underscores their potential as both direct and indirect targets for cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

SLCcolon cancerliver cancerlung cancerpancreatic cancertransporter

Autor:innen und Institutionen

  • Department of Infectious Diseases, UMass Chan Medical School, Worcester, MA 01605, USA.
  • Department of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA 01605, USA.

ORCID-Profile: Swati Jaiswal, Erandi E Velarde de la Cruz, Ritesh P Thakare

Zitieren

APA

Bharadwaj, R., Jaiswal, S., Velarde de la Cruz, E. E., & Thakare, R. P. (2024). Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers. Diseases, 12(3), 63. https://doi.org/10.3390/diseases12030063

Vancouver

Bharadwaj R, Jaiswal S, Velarde de la Cruz EE, Thakare RP. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers. Diseases. 2024;12(3):63. doi:10.3390/diseases12030063

BibTeX
@article{Bharadwaj2024,
  author = {Bharadwaj, Ravi and Jaiswal, Swati and Velarde de la Cruz, Erandi E and Thakare, Ritesh P},
  title = {Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers},
  journal = {Diseases},
  year = {2024},
  volume = {12},
  number = {3},
  pages = {63},
  doi = {10.3390/diseases12030063}
}
Kostenlos starten →